Insulin-like Factor 3 Emerges from the Shadow of Testosterone as a Leydig Cell Biomarker
- 7 September 2020
- journal article
- editorial
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 106 (1), e370-e371
- https://doi.org/10.1210/clinem/dgaa603
Abstract
Jorma Toppari; Insulin-like factor 3 emerges from the shadow of testosterone as a Leydig cell biomarker, The Journal of Clinical Endocrinology & Metabolism, ,Keywords
This publication has 7 references indexed in Scilit:
- Longitudinal Increases in Serum Insulin-like Factor 3 and Testosterone Determined by LC-MS/MS in Pubertal Danish BoysJournal of Clinical Endocrinology & Metabolism, 2020
- Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell FunctionJournal of Clinical Endocrinology & Metabolism, 2020
- INSL3 in the muscolo-skeletal systemMolecular and Cellular Endocrinology, 2019
- Development and validation of a mass spectrometry-based assay for quantification of insulin-like factor 3 in human serumcclm, 2018
- Insulin-like peptide 3 (INSL3) is a major regulator of female reproductive physiologyHuman Reproduction Update, 2018
- Testicular descent: INSL3, testosterone, genes and the intrauterine milieuNature Reviews Urology, 2011
- Paracrine regulation of mammalian oocyte maturation and male germ cell survivalProceedings of the National Academy of Sciences of the United States of America, 2004